Borrowings (Tables)	9 Months Ended
	Sep. 30, 2021
Borrowings [Abstract]
Summary Of Borrowings	As of September 30, 2021(Dollars in thousands) Maturity Date Contractual‎Facility Balance,‎Gross Balance,‎Net(1) Stated‎Interest Rate Effective‎Interest‎RateDenominated in USD Trust Preferred Securities (USA) April 30, 2027 $ 27,913  $ 27,913  $ 26,672 4.13% 4.13%Bank of America Credit Facility (USA) March 6, 2023 55,000  42,800 42,645 4.00% 4.00%Bank of America Line of Credit (USA) March 6, 2023 5,000  5,000  5,000  3.08% 3.08%Cinemas 1, 2, 3 Term Loan (USA) April 1, 2022 24,189 24,189 23,826 4.25% 4.25%Minetta & Orpheum Theatres Loan (USA)(2) November 1, 2023 8,000  8,000  7,936 2.14% 5.15%U.S. Corporate Office Term Loan (USA) January 1, 2027 9,000 9,000 8,920 4.64% / 4.44% 4.61%Purchase Money Promissory Note (USA) September 18, 2024 2,216 2,216 2,216 5.00% 5.00%Union Square Financing (USA) May 6, 2024 55,000 43,000  41,920 7.00% 7.00%Denominated in foreign currency ("FC") (3) NAB Corporate Term Loan (AU) December 31, 2023 74,087 74,087 73,944 1.81% 1.81%Westpac Bank Corporate (NZ) December 31, 2023 9,548 9,548 9,548 2.95% 2.95% $ 269,953 $ 245,753 $ 242,627 (1)Net of deferred financing costs amounting to $3.1 million.(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of September 30, 2021. As of December 31, 2020(Dollars in thousands) Maturity Date Contractual‎Facility Balance,‎Gross Balance,Net(1) Stated‎Interest‎Rate EffectiveInterestRateDenominated in USD Trust Preferred Securities (USA) April 30, 2027 $ 27,913  $ 27,913  $ 26,505 4.27% 4.27%Bank of America Credit Facility (USA) March 6, 2023 55,000  51,200 50,990 4.00% 4.00%Bank of America Line of Credit (USA) March 6, 2023 5,000  5,000 5,000 3.15% 3.15%Cinemas 1, 2, 3 Term Loan (USA) April 1, 2022 24,625 24,625 24,248 4.25% 4.25%Minetta & Orpheum Theatres Loan (USA)(2) November 1, 2023 8,000 8,000 7,914 2.20% 5.15%U.S. Corporate Office Term Loan (USA) January 1, 2027 9,186 9,186 9,095 4.64% / 4.44% 4.64%Union Square Financing (USA) March 31, 2021 50,000 40,623 40,620 17.50% 17.50%Purchase Money Promissory Note September 18, 2024 2,883 2,883 2,883 5.00% 5.00%Denominated in foreign currency ("FC")(3) NAB Corporate Term Loan (AU) December 31, 2023 94,821 92,508 92,307 1.81% 1.81%Westpac Bank Corporate (NZ) December 31, 2023 23,021 23,021 23,021 2.95% 2.95%Total $ 300,449 $ 284,959 $ 282,583 (1)Net of deferred financing costs amounting to $2.4 million. (2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2020.
Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs	September 30, December 31,Balance Sheet Caption 2021 2020Debt - current portion $ 2,586 $ 41,459Debt - long-term portion 212,667 213,779Subordinated debt - current portion 702 840Subordinated debt - long-term portion 26,672 26,505Total borrowings $ 242,627 $ 282,583